FINWIRES · TerminalLIVE
FINWIRES

Moleculin Biotech Files Registration Statement for Public Offering; Shares Fall

By

Moleculin Biotech (MBRX) filed a registration statement Wednesday with the US Securities and Exchange Commission for the sale of shares and warrants to raise net proceeds of an estimated $9.1 million.

The company said it proposes to sell up to 4.6 million common shares at an assumed offering price of $2.19 apiece. It is also offering 4.6 million prefunded warrants and 13.7 million common warrants.

Each share is being offered together with three common warrants, each to purchase one share of common stock, the company said.

Moleculin said it intends to use the net proceeds to advance its Annamycin chemotherapy drug through clinical development and for working capital.

The offering is expected to close on Aug. 14, the company said.

Shares of the company were down 36% in Wednesday trading.

Price: $1.38, Change: $-0.81, Percent Change: -36.99%

Related Articles

Wire

Orion Q2 Adjusted Earnings Fall, Revenue Rises; Cuts 2026 EPS Guidance

Orion Group (ORN) reported Q2 adjusted earnings late Tuesday of $0.02 per share, down from $0.07 a year earlier.Analysts polled by FactSet expected $0.06.Revenue for the quarter ended June 30 rose to $221.9 million from $205.3 million a year earlier.Analysts expected $225.7 million.The company now expects 2026 adjusted EPS of $0.23 to $0.30, compared with $0.36 to $0.42 earlier. The company continues to see full-year revenue of $900 million to $950 million.Analysts expect $0.39 and $938.9 million, respectively.Shares of Orion were down 8% in after-hours activity.

$ORN
Wire

Rogers Q2 Adjusted Earnings, Revenue Rise

Rogers (ROG) reported Q2 adjusted earnings late Tuesday of $0.92 per diluted share, up from $0.34 a year earlier.Three analysts polled by FactSet expected $0.99.Revenue in the three months ended June 30 rose to $216.8 million from $202.8 million a year earlier.Three analysts surveyed by FactSet expected $215 million.The company expects Q3 adjusted EPS of $1.10 to $1.30 on revenue of $233 million to $243 million.Three analysts expect EPS of $1.03 on revenue of $225.5 million.The company's shares fell 2% in after-hours trading.

$ROG
Wire

Extra Space Storage Q2 Core FFO, Revenue Rise

Extra Space Storage (EXR) reported Q2 core funds from operations late Tuesday of $2.15 per diluted share, up from $2.05 a year earlier.Analysts polled by FactSet expected $2.07.Revenue for the three months ended June 30 rose to $874.2 million from $841.6 million a year earlier.Analysts expected $875 million.The company raised full-year core FFO guidance to $8.25 to $8.40 a share from the prior range of $8.05 to 8.35. Analysts expect $8.29.The company's shares fell 1.5% in after-hours trading.

$EXR